Steve Elms, Director at ADMA BIOLOGICS, INC. (ADMA), bought 14,000 shares at $15.67 ($217K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Seasonal purchase ($217k) by Director — this insider has traded ADMA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.67 | 7,000 | $110K | 50.5% |
| 2 | $15.39 | 7,000 | $108K | 49.5% |
| Total | $15.53 avg | 14,000 | $217K | 100% |
| Filing → |
| ADMA | SELL | 2024-03-19 | $5.6M | — | Filing → |
| ADMA | SELL | 2024-03-15 | $10.2M | — | Filing → |
| MRKR | BUY | 2021-03-18 | $4.0M | — | Filing → |